Safety evaluation of certain food additives - ipcs inchem

More documents

Recommendations

Info

ANNEX 5 SUMMARY OF THE SAFETY EVALUATION OF SECONDARY COMPONENTS FOR FLAVOURING AGENTS WITH MINIMUM ASSAY VALUES OF LESS THAN 95% - 631 -
632 ANNEX 5 Secondary components Comments on secondary components JECFA No. Flavouring agent Minimum assay value (%) Aliphatic branched-chain saturated and unsaturated alcohols, aldehydes, acids and related esters 90%
Page 2 and 3:
WHO FOOD ADDITIVES SERIES: 60 Safet
Page 4 and 5:
CONTENTS Preface ..................
Page 6:
PREFACE The monographs contained in
Page 10 and 11:
ASPARAGINASE FROM ASPERGILLUS NIGER
Page 12 and 13:
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20:
Page 23 and 24:
16 CALCIUM LIGNOSULFONATE (40-65) 1
Page 25 and 26:
18 CALCIUM LIGNOSULFONATE (40-65) ~
Page 27 and 28:
20 CALCIUM LIGNOSULFONATE (40-65) A
Page 29 and 30:
22 CALCIUM LIGNOSULFONATE (40-65) c
Page 31 and 32:
24 CALCIUM LIGNOSULFONATE (40-65) T
Page 33 and 34:
Page 35 and 36:
28 CALCIUM LIGNOSULFONATE (40-65) i
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 46 and 47:
ETHYL LAUROYL ARGINATE First draft
Page 48 and 49:
ETHYL LAUROYL ARGINATE 41 and Devel
Page 50 and 51:
ETHYL LAUROYL ARGINATE 43 lauroyl a
Page 52 and 53:
ETHYL LAUROYL ARGINATE 45 arginine.
Page 54 and 55:
ETHYL LAUROYL ARGINATE 47 resulting
Page 56 and 57:
ETHYL LAUROYL ARGINATE 49 Table 4.
Page 58 and 59:
ETHYL LAUROYL ARGINATE 51 weight ch
Page 60 and 61:
ETHYL LAUROYL ARGINATE 53 stomach l
Page 62 and 63:
ETHYL LAUROYL ARGINATE 55 fibrosis
Page 64 and 65:
ETHYL LAUROYL ARGINATE 57 Table 5 (
Page 66 and 67:
ETHYL LAUROYL ARGINATE 59 first 4 d
Page 68 and 69:
ETHYL LAUROYL ARGINATE 61 The gener
Page 70 and 71:
ETHYL LAUROYL ARGINATE 63 treatment
Page 72 and 73:
ETHYL LAUROYL ARGINATE 65 gestation
Page 74 and 75:
ETHYL LAUROYL ARGINATE 67 Body weig
Page 76 and 77:
ETHYL LAUROYL ARGINATE 69 Table 6.
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
ETHYL LAUROYL ARGINATE 77 About 99%
Page 86 and 87:
ETHYL LAUROYL ARGINATE 79 concentra
Page 88 and 89:
ETHYL LAUROYL ARGINATE 81 theoretic
Page 90 and 91:
ETHYL LAUROYL ARGINATE 83 Huntingdo
Page 92 and 93:
PAPRIKA EXTRACT First draft prepare
Page 94 and 95:
PAPRIKA EXTRACT 87 of capsanthin ra
Page 96 and 97:
PAPRIKA EXTRACT 89 biochemical para
Page 98 and 99:
PAPRIKA EXTRACT 91 Table 1. Sales o
Page 100 and 101:
PAPRIKA EXTRACT 93 Table 2. Estimat
Page 102 and 103:
PAPRIKA EXTRACT 95 The European Sci
Page 104 and 105:
PAPRIKA EXTRACT 97 The potential di
Page 106 and 107:
PAPRIKA EXTRACT 99 Hornero-Mendez,
Page 108 and 109:
PAPRIKA EXTRACT 101 Appendix 1. Res
Page 110 and 111:
PAPRIKA EXTRACT 103 Appendix 1. (co
Page 112:
PAPRIKA EXTRACT 105 Appendix 1. (co
Page 115 and 116:
108 PHOSPHOLIPASE C EXPRESSED IN PI
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 124 and 125:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170:
Page 173 and 174:
166 POLYDIMETHYLSILOXANE (addendum)
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 190 and 191:
STEVIOL GLYCOSIDES (addendum) First
Page 192 and 193:
STEVIOL GLYCOSIDES (addendum) 185 r
Page 194 and 195:
STEVIOL GLYCOSIDES (addendum) 187 c
Page 196 and 197:
STEVIOL GLYCOSIDES (addendum) 189 a
Page 198 and 199:
STEVIOL GLYCOSIDES (addendum) 191 N
Page 200 and 201:
STEVIOL GLYCOSIDES (addendum) 193 2
Page 202 and 203:
STEVIOL GLYCOSIDES (addendum) 195 T
Page 204 and 205:
STEVIOL GLYCOSIDES (addendum) 197 a
Page 206 and 207:
STEVIOL GLYCOSIDES (addendum) 199 r
Page 208 and 209:
STEVIOL GLYCOSIDES (addendum) 201 l
Page 210 and 211:
STEVIOL GLYCOSIDES (addendum) 203 g
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
STEVIOL GLYCOSIDES (addendum) 209 t
Page 218 and 219:
STEVIOL GLYCOSIDES (addendum) 211 t
Page 220 and 221:
STEVIOL GLYCOSIDES (addendum) 213 s
Page 222 and 223:
STEVIOL GLYCOSIDES (addendum) 215 C
Page 224 and 225:
STEVIOL GLYCOSIDES (addendum) 217 L
Page 226:
STEVIOL GLYCOSIDES (addendum) 219 W
Page 229 and 230:
222 SULFITES: ASSESSMENT OF DIETARY
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 268:
SAFETY EVALUATIONS OF GROUPS OF REL
Page 271 and 272:
264 INTRODUCTION Figure 1. Procedur
Page 274 and 275:
DIETARY EXPOSURE ASSESSMENT OF FLAV
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296:
Page 299 and 300:
292 ALIPHATIC BRANCHED-CHAIN SATURA
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
332 ALIPHATIC LINEAR ,-UNSATURATED
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 358 and 359:
ALKOXY-SUBSTITUTED ALLYLBENZENES PR
Page 360 and 361:
ALKOXY-SUBSTITUTED ALLYLBENZENES 35
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 380 and 381:
Page 382 and 383:
Page 384 and 385:
Page 386 and 387:
Page 388 and 389:
Page 390 and 391:
Page 392 and 393:
Page 394 and 395:
Page 396 and 397:
Page 398 and 399:
Page 400 and 401:
Page 402 and 403:
Page 404 and 405:
Page 406 and 407:
Page 408 and 409:
Page 410 and 411:
Page 412 and 413:
Page 414 and 415:
Page 416 and 417:
Page 418 and 419:
Page 420 and 421:
Page 422 and 423:
Page 424 and 425:
Page 426 and 427:
Page 428 and 429:
Page 430 and 431:
Page 432 and 433:
Page 434 and 435:
Page 436 and 437:
Page 438 and 439:
Page 440 and 441:
Page 442 and 443:
Page 444 and 445:
Page 446 and 447:
Page 448 and 449:
Page 450 and 451:
Page 452 and 453:
Page 454 and 455:
Page 456 and 457:
Page 458 and 459:
Page 460 and 461:
Page 462 and 463:
Page 464 and 465:
Page 466 and 467:
Page 468 and 469:
Page 470 and 471:
Page 472 and 473:
Page 474 and 475:
Page 476 and 477:
Page 478 and 479:
Page 480 and 481:
Page 482 and 483:
Page 484 and 485:
Page 486 and 487:
Page 488 and 489:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
Page 490 and 491:
Page 492 and 493:
Page 494 and 495:
Page 496 and 497:
Page 498 and 499:
Page 500 and 501:
Page 502 and 503:
Page 504 and 505:
Page 506 and 507:
Page 508 and 509:
Page 510 and 511:
Page 512 and 513:
Page 514 and 515:
Page 516 and 517:
Page 518 and 519:
Page 520 and 521:
Page 522 and 523:
Page 524 and 525:
Page 526 and 527:
Page 528 and 529:
Page 530 and 531:
Page 532 and 533:
Page 534 and 535:
Page 536 and 537:
Page 538 and 539:
Page 540 and 541:
HYDROXY- AND ALKOXY-SUBSTITUTED BEN
Page 542 and 543:
Page 544 and 545:
Page 546 and 547:
Page 548 and 549:
Page 550 and 551:
Page 552 and 553:
Page 554 and 555:
Page 556 and 557:
MISCELLANEOUS NITROGEN-CONTAINING S
Page 558 and 559:
Page 560 and 561:
Page 562 and 563:
Page 564 and 565:
Page 566 and 567:
Page 568 and 569:
Page 570 and 571:
Page 572 and 573:
Page 574 and 575:
Page 576 and 577:
Page 578 and 579:
Page 580 and 581:
Page 582 and 583:
Page 584:
Page 587 and 588: 580 SUBSTANCES STRUCTURALLY RELATED
Page 602: ANNEXES
Page 605 and 606: 598 ANNEX 1 10. Specifications for
Page 607 and 608: 600 ANNEX 1 No. 54, 1974; WHO Techn
Page 609 and 610: 602 ANNEX 1 70. Evaluation of certa
Page 611 and 612: 604 ANNEX 1 108. Toxicological eval
Page 613 and 614: 606 ANNEX 1 148. Residues of some v
Page 615 and 616: 608 ANNEX 1 188. Safety evaluation
Page 617 and 618: 610 ANNEX 2 ECG electrocardiogram E
Page 619 and 620: 612 ANNEX 2 SI stimulation index SU
Page 621 and 622: 614 ANNEX 3 Ms J. Baines, Food Stan
Page 624 and 625: ANNEX 4 ACCEPTABLE DAILY INTAKES, O
Page 626 and 627: ANNEX 4 619 Food additive Specifica
Page 628 and 629: ANNEX 4 621 3. FLAVOURING AGENTS 3.
Page 630 and 631: ANNEX 4 623 Flavouring agent No. Sp
Page 632 and 633: ANNEX 4 625 Flavouring agent JECFA
Page 634 and 635: ANNEX 4 627 Actual production volum
Page 636 and 637: ANNEX 4 629 Flavouring agent No. Sp
Page 640 and 641: ANNEX 5 633 Secondary components Co
show all

Safety evaluation of certain food additives - ipcs inchem

Create successful ePaper yourself

Delete template?

Save as template?